Assessing Menopausal Status in Women Aged 40-49 Using Depot-Medroxyprogesterone Acetate, Norethisterone Enanthate Or Combined Oral Contraception (Original Articles) (Report)

Assessing Menopausal Status in Women Aged 40-49 Using Depot-Medroxyprogesterone Acetate, Norethisterone Enanthate Or Combined Oral Contraception (Original Articles) (Report)

Determining the onset of menopause in older users of hormonal injectable contraceptives depot medroxyprogesterone acetate (DMPA) and norethisterone enanthate (NET-EN) can be challenging. These contraceptive methods may mask menopausal symptoms such as amenorrhoea, which is a common side-effect of the method itself and increases in incidence over length of time used. (1) DMPA has been […]